メタボロミクスの世界市場レポート 2025年

メタボロミクスの市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR17.6％で79億9,000万米ドルに成長すると予測されます。予測期間の成長は、個別化ヘルスケア、薬剤の安全性と有効性、マイクロバイオームと腸の健康、環境と農業への応用、再生医療に起因すると考えられます。予測期間の主な動向には、他のオミクスとの統合、標的化メタボロミクス、シングルセルメタボロミクス、データ解析とAI、ポイントオブケア検査が含まれます。

がん罹患率の増加がメタボロミクス市場の成長促進要因となっています。メタボロミクスは、潜在的なバイオマーカーを精査して抗がん剤の反応性を評価するもので、がんの早期診断に重要な役割を果たしています。例えば、米国を拠点とする専門機関である米国がん協会によると、2023年には米国で195万8,310人の新規がん患者と60万9,820人のがん死亡者が発生すると予測されており、前年より増加します。核磁気共鳴法（NMR）や質量分析法（MS）などの調査手法は、がんの研究において極めて重要です。Metabolon Inc.やBruker Corp.のような企業は、メタボロミクスを統合し、がんの早期発見と治療に役立てています。

慢性疾患の増加は、メタボロミクス市場の成長を当面牽引するものと思われます。慢性疾患は1年以上続くため、継続的な医療介入が必要となり、日常生活に支障をきたすことも少なくありません。メタボロミクスは、慢性疾患の代謝的背景を明らかにし、適切なバイオマーカーを特定し、代替療法の潜在的標的を突き止める上で重要な役割を果たしています。生物の表現型に直結するその能力は、病気や健康に関する研究において非常に貴重なツールとなります。オーストラリア統計局による2022年3月の報告書で強調されたように、オーストラリア人のほぼ4分の3（78.6%）が少なくとも1つの長期的な健康問題を報告し、人口のほぼ半数（46.6%、1,160万人）が慢性疾患の影響を受けています。したがって、慢性疾患の増加はメタボロミクス市場拡大の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のメタボロミクス市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のメタボロミクス市場：成長率分析
• 世界のメタボロミクス市場の実績：規模と成長、2019～2024年
• 世界のメタボロミクス市場の予測：規模と成長、2024～2029年、2034年
• 世界のメタボロミクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のメタボロミクス市場：製品とサービス別、実績と予測、2019～2024年、2024～2029年、2034年
• メタボロミクス機器
• メタボロミクスバイオインフォマティクスツールとサービス
• 世界のメタボロミクス市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• がん
• 心血管疾患
• 神経疾患
• 先天性代謝異常
• その他
• 世界のメタボロミクス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• バイオマーカー探索
• 創薬
• 毒性試験
• 栄養ゲノミクス
• 機能ゲノミクス
• 個別化医療
• その他
• 世界のメタボロミクス市場：メタボロミクス機器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• クロマトグラフィー機器
• 質量分析装置
• NMR機器
• その他
• 世界のメタボロミクス市場：メタボロミクスバイオインフォマティクスツールとサービスのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ソフトウェアツール
• データベースサービス
• コンサルティングサービス
• トレーニングおよびサポートサービス

第7章 地域別・国別分析

• 世界のメタボロミクス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のメタボロミクス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• メタボロミクス市場：競合情勢
• メタボロミクス市場：企業プロファイル
  • Human Metabolome Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Metabolon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Thermo Fisher Scientific Inc.
• Waters Corporation
• Biocrates Life Sciences AG
• Shimadzu Corporation
• Danaher Corporation
• Kore Technologies Ltd.
• Dani Instruments SpA
• Perkinelmer Inc.
• Evans Analytical Group LLC
• LECO Corporation
• Phenomenome Discoveries Inc.
• AB Sciex
• BG Medicine Inc.
• Biomark Diagnostics Inc.
• Chenomx Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• メタボロミクス市場2029：新たな機会を提供する国
• メタボロミクス市場2029：新たな機会を提供するセグメント
• メタボロミクス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Metabolomics is the scientific study of small molecules known as metabolites, which are produced during metabolism within cells, tissues, or organisms. By analyzing and quantifying these metabolites, metabolomics provides valuable insights into biological processes, disease mechanisms, and metabolic pathways. This field plays a critical role in personalized medicine, drug discovery, and understanding the mechanisms of diseases such as cancer and diabetes.

The key products and services in the field of metabolomics encompass metabolomics instruments, metabolomics bioinformatics tools, and various services. Metabolomics instruments are specialized devices employed to comprehensively analyze low-molecular-weight compounds within biological samples. These instruments include separation techniques, detection methodologies, and metabolomics bioinformatics tools and services, which involve databases and bioinformatics tools. Metabolomics finds application in diverse medical indications such as cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. These applications are utilized for purposes such as biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and more.

The metabolomics market research report is one of a series of new reports from The Business Research Company that provides metabolomics market statistics, including metabolomics industry global market size, regional shares, competitors with a metabolomics market share, detailed metabolomics market segments, market trends and opportunities, and any further data you may need to thrive in the metabolomics industry. This metabolomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metabolomics market size has grown rapidly in recent years. It will grow from $3.62 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to advancements in healthcare, drug discovery and development, disease biomarker identification, academic and research institutions, nutrition and food science.

The metabolomics market size is expected to see rapid growth in the next few years. It will grow to $7.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to personalized healthcare, drug safety and efficacy, microbiome and gut health, environmental and agricultural applications, regenerative medicine. Major trends in the forecast period include integration with other omics, targeted metabolomics, single-cell metabolomics, data analytics and ai, point-of-care testing.

The increasing incidence of cancer is a primary driver of growth within the metabolomics market. Metabolomics, which scrutinizes potential biomarkers to assess cancer drug responsiveness, plays a vital role in early cancer diagnosis. For instance, in 2023, according to the American Cancer Society, a US-based professional organization, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States, marking an increase from the previous year. Metabolomics methodologies, including nuclear magnetic resonance (NMR) and mass spectrometry (MS) techniques, are pivotal in studying cancer. Companies like Metabolon Inc. and Bruker Corp. have integrated metabolomics to aid in early cancer detection and treatment.

The rising prevalence of chronic diseases is poised to drive the metabolomics market's growth in the foreseeable future. Chronic ailments persist for a year or longer, necessitating ongoing medical intervention and often hindering daily activities. Metabolomics plays a crucial role in uncovering the metabolic underpinnings of chronic diseases, identifying pertinent biomarkers, and pinpointing potential targets for alternative therapies. Its ability to directly connect with an organism's phenotype makes it an invaluable tool in disease and health research. As highlighted in a March 2022 report by the Australian Bureau of Statistics, nearly three-quarters of Australians (78.6%) reported at least one long-term health issue, with almost half of the population (46.6% or 11.6 million individuals) affected by chronic conditions. Hence, the increasing prevalence of chronic diseases is a driving force behind the expansion of the metabolomics market.

The integration of machine learning is increasingly popular within the metabolomics field, significantly enhancing the efficiency of interpreting data obtained from metabolomics techniques. Machine learning-powered technologies automate complex and risky processes, streamline tasks, and offer swift, error-free services. Industry companies are favoring machine learning techniques for metabolism analysis, solving problems, and executing tasks. Various machine learning algorithms aid in metabolism data analysis and modeling metabolic pathways. Companies like Bio-Rad Laboratories, Metabolon Inc., among others, are leveraging machine learning algorithms to enhance understanding and prediction in metabolomics research. For example, MeltDB 2.0, a machine learning software utilized for metabolomics experiment data analysis and integration, provides robust research support, storing experimental datasets, and comprehensive analysis and visualization features to represent large and complex data effectively.

Major companies operating in the metabolomics market are focusing on introducing Integrated Bioinformatics Platforms to enhance the interpretation of complex metabolomic data, supporting advancements in personalized medicine, biomarker discovery, and disease understanding. An Integrated Bioinformatics Platform is a comprehensive software solution that combines various bioinformatics tools and databases, facilitating the analysis and interpretation of biological data. Researchers can map metabolomics data against precise biochemical pathway maps, helping to uncover biological processes and disease mechanisms. For instance, in February 2024, Metabolon, Inc., a US-based company, launched its bioinformatics platform. The "Biomarker Lenses" feature in the Integrated Bioinformatics Platform allows users to apply advanced analytical filters, focusing on metabolites linked to specific pathways or diseases, enabling targeted exploration of metabolomic data. The platform also includes tools for conducting statistical analyses like T-tests and ANOVAs, allowing researchers to build and compare statistical models, manage metadata, and visualize results effectively.

In October 2022, Clinical Microbiomics, a Denmark-based microbiome research company, acquired MS-Omics, a Denmark-based metabolomics company, for an undisclosed sum. This acquisition bolstered Clinical Microbiomics' portfolio by adding specialized metabolic profiling offerings. The addition of MS-Omics' capabilities is set to advance Clinical Microbiomics' systems biology platform, benefiting researchers globally.

Major companies operating in the metabolomics market include Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, Kore Technologies Ltd., Dani Instruments SpA, Perkinelmer Inc., Evans Analytical Group LLC, LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Biomark Diagnostics Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Southern Research Company Inc., Alcami Corporation, Charles River Laboratories International Inc., Eremid Genomic Services LLC, Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.

North America was the largest region in the metabolomics market in 2024. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the metabolomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The metabolomics market includes revenue earned by liquid chromatography, gas chromatography, capillary electrophoresis, mass spectrometry, and nuclear magnetic resonance spectroscopy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metabolomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metabolomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metabolomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metabolomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Metabolomics Instruments; Metabolomics Bioinformatics Tools And Services
• 2) By Indication: Cancer; Cardiovascular Disorders; Neurological Disorders; Inborn Errors of Metabolism; Other Indications
• 3) By Application: Biomarker Discovery; Drug Discovery; Toxicology Testing; Nutrigenomics; Functional Genomics; Personalized Medicine; Other Applications
• Subsegments:
• 1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography); Mass Spectrometry Instruments (LC-MS, GC-MS); NMR Instruments (Nuclear Magnetic Resonance); Others (Spectroscopy Instruments, Microarrays)
• 2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools); Database Services (Metabolomic Databases); Consulting Services (Data Interpretation, Analytical Support); Training And Support Services
• Companies Mentioned: Human Metabolome Technologies Inc.; Metabolon Inc.; Bio-Rad Laboratories Inc.; Bruker Corporation; Agilent Technologies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metabolomics Market Characteristics

3. Metabolomics Market Trends And Strategies

4. Metabolomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Metabolomics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Metabolomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Metabolomics Market Growth Rate Analysis
• 5.4. Global Metabolomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Metabolomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Metabolomics Total Addressable Market (TAM)

6. Metabolomics Market Segmentation

• 6.1. Global Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metabolomics Instruments
• Metabolomics Bioinformatics Tools & Services
• 6.2. Global Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Other Indications
• 6.3. Global Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Personalized Medicine
• Other Applications
• 6.4. Global Metabolomics Market, Sub-Segmentation Of Metabolomics Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chromatography Instruments
• Mass Spectrometry Instruments
• NMR Instruments
• Others
• 6.5. Global Metabolomics Market, Sub-Segmentation Of Metabolomics Bioinformatics Tools And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software Tools
• Database Services
• Consulting Services
• Training And Support Services

7. Metabolomics Market Regional And Country Analysis

• 7.1. Global Metabolomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Metabolomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metabolomics Market

• 8.1. Asia-Pacific Metabolomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metabolomics Market

• 9.1. China Metabolomics Market Overview
• 9.2. China Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metabolomics Market

• 10.1. India Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metabolomics Market

• 11.1. Japan Metabolomics Market Overview
• 11.2. Japan Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metabolomics Market

• 12.1. Australia Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metabolomics Market

• 13.1. Indonesia Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metabolomics Market

• 14.1. South Korea Metabolomics Market Overview
• 14.2. South Korea Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metabolomics Market

• 15.1. Western Europe Metabolomics Market Overview
• 15.2. Western Europe Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metabolomics Market

• 16.1. UK Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metabolomics Market

• 17.1. Germany Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metabolomics Market

• 18.1. France Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metabolomics Market

• 19.1. Italy Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metabolomics Market

• 20.1. Spain Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metabolomics Market

• 21.1. Eastern Europe Metabolomics Market Overview
• 21.2. Eastern Europe Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metabolomics Market

• 22.1. Russia Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metabolomics Market

• 23.1. North America Metabolomics Market Overview
• 23.2. North America Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metabolomics Market

• 24.1. USA Metabolomics Market Overview
• 24.2. USA Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metabolomics Market

• 25.1. Canada Metabolomics Market Overview
• 25.2. Canada Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metabolomics Market

• 26.1. South America Metabolomics Market Overview
• 26.2. South America Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metabolomics Market

• 27.1. Brazil Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metabolomics Market

• 28.1. Middle East Metabolomics Market Overview
• 28.2. Middle East Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metabolomics Market

• 29.1. Africa Metabolomics Market Overview
• 29.2. Africa Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Metabolomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metabolomics Market Competitive Landscape And Company Profiles

• 30.1. Metabolomics Market Competitive Landscape
• 30.2. Metabolomics Market Company Profiles
  • 30.2.1. Human Metabolome Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Metabolon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Metabolomics Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. Waters Corporation
• 31.3. Biocrates Life Sciences AG
• 31.4. Shimadzu Corporation
• 31.5. Danaher Corporation
• 31.6. Kore Technologies Ltd.
• 31.7. Dani Instruments SpA
• 31.8. Perkinelmer Inc.
• 31.9. Evans Analytical Group LLC
• 31.10. LECO Corporation
• 31.11. Phenomenome Discoveries Inc.
• 31.12. AB Sciex
• 31.13. BG Medicine Inc.
• 31.14. Biomark Diagnostics Inc.
• 31.15. Chenomx Inc.

32. Global Metabolomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metabolomics Market

34. Recent Developments In The Metabolomics Market

35. Metabolomics Market High Potential Countries, Segments and Strategies

• 35.1 Metabolomics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Metabolomics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Metabolomics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer